i2E & Plains Ventures Surpasses $100M Milestone in Total Investments
Innovation 2 Enterprise
NOVEMBER 21, 2024
billion at its IPO in April 2021.The By leveraging its extensive network and resources, i2E is committed to supporting innovation, driving economic development, and nurturing a thriving entrepreneurial community. Novazyme Pharmaceuticals Inc. was acquired by Genzyme Corp for $137.5 million in 2001.
Let's personalize your content